- Home
- RGS vs BRNS Comparison
RGS vs BRNS Comparison
Compare RGS & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGS
- BRNS
- Stock Information
- Founded
- RGS 1922
- BRNS 2016
- Country
- RGS United States
- BRNS United Kingdom
- Employees
- RGS N/A
- BRNS N/A
- Industry
- RGS Other Consumer Services
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- RGS Consumer Discretionary
- BRNS Health Care
- Exchange
- RGS Nasdaq
- BRNS Nasdaq
- Market Cap
- RGS 70.8M
- BRNS 48.3M
- IPO Year
- RGS 1991
- BRNS 2021
- Fundamental
- Price
- RGS $29.12
- BRNS $1.08
- Analyst Decision
- RGS
- BRNS Strong Buy
- Analyst Count
- RGS 0
- BRNS 1
- Target Price
- RGS N/A
- BRNS $3.00
- AVG Volume (30 Days)
- RGS 25.2K
- BRNS 42.9K
- Earning Date
- RGS 11-05-2025
- BRNS 11-05-2025
- Dividend Yield
- RGS N/A
- BRNS N/A
- EPS Growth
- RGS 20.23
- BRNS N/A
- EPS
- RGS 46.10
- BRNS N/A
- Revenue
- RGS $210,134,000.00
- BRNS $14,969,000.00
- Revenue This Year
- RGS N/A
- BRNS N/A
- Revenue Next Year
- RGS N/A
- BRNS N/A
- P/E Ratio
- RGS $0.65
- BRNS N/A
- Revenue Growth
- RGS 3.52
- BRNS 1766.46
- 52 Week Low
- RGS $15.00
- BRNS $0.64
- 52 Week High
- RGS $30.29
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- RGS 72.28
- BRNS 42.62
- Support Level
- RGS $27.50
- BRNS $0.99
- Resistance Level
- RGS $30.29
- BRNS $1.20
- Average True Range (ATR)
- RGS 1.53
- BRNS 0.08
- MACD
- RGS 0.46
- BRNS -0.01
- Stochastic Oscillator
- RGS 87.54
- BRNS 24.86
About RGS Regis Corporation
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.